Publications by authors named "Kathleen Lundeberg"

Background The goals of the annual Council on Resident Education in Obstetrics and Gynecology In-Training Examination (CREOG-ITE) are to provide residents with an assessment of their knowledge and program directors an assessment of their residency programs. Research has shown that a score greater than 200 is correlated with passing the qualifying board examination. We observed a substantial number of our residents were not performing well on the exam, which prompted the implementation of a new academic program aimed at determining the impact of an academic curriculum addition on CREOG-ITE scores in an American College of Graduate Medical Education (ACGME) accredited obstetrics and gynecology (OB/GYN) residency program.

View Article and Find Full Text PDF

Endometrial cancer is the most common gynecologic malignancy in the United States, with a prevalence of 25.7 per 100,000 women per year (Mahdy et al., 2023).

View Article and Find Full Text PDF

Background: In the United States, Black women die at 2.5 times the rate of White women and 3.5 times the rate of Hispanic women.

View Article and Find Full Text PDF

Background: Rates of maternal morbidity and mortality experienced by women in the United States have been shown to vary significantly by race, most commonly attributed to differences in access to healthcare and socioeconomic status. Recent data showed that Asian Pacific Islanders have the highest rate of maternal morbidity despite having a higher socioeconomic status. In the military, women of all races are granted equal access to healthcare, irrespective of socioeconomic class.

View Article and Find Full Text PDF

Soft tissue sarcomas (STSs) are rare and may often be misdiagnosed, resulting in delays in treatment. A 67-year-old cisgender woman with type 2 diabetes mellitus and obesity presented to her primary care physician with a mass on her left proximal arm. The clinical opinion of the attending physician was that of an insulin injection site reaction.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 2 trial was conducted to evaluate the effectiveness of ofatumumab, a humanized monoclonal antibody, in treating patients with relapsed/refractory chronic lymphocytic leukemia (CLL), using fresh frozen plasma (FFP) for complement replacement.
  • The trial enrolled 12 patients, achieving an overall response rate of 83%, with 17% reaching complete response, though many experienced low complement activity post-treatment, and the degree of complement depletion did not correlate with treatment outcomes.
  • Results suggest that combining ofatumumab with FFP is both tolerable and effectively active in high-risk CLL patients, indicating that further studies on complement replacement could enhance monoclonal antibody
View Article and Find Full Text PDF

Non-Hodgkin lymphoma (NHL) affects over 400,000 people in the United States; its incidence increases with age. Treatment options are numerous and expanding, yet efficacy is often limited by toxicity, particularly in the elderly. Nearly 70% patients eventually die of the disease.

View Article and Find Full Text PDF